TOM Medications concludes another round of funding at over CHF 1.3 million
The latest round of funding for TOM Medications was hugely oversubscribed, at CHF 1.3 million, or over 120 percent. TOM Medications hopes the new funding will help boost its turnover, expand its community, and tap into new markets.(Wermatswil/Zurich) TOM Medications has already notched numerous successes since its launch in June 2020. Around 30 million interactions have already taken place via the app, and treatment compliance among TOM app users is 83 percent – much higher than the approximate average of 50 percent usually achieved by those with chronic health conditions. As the recent